miR-200c enhances sensitivity of drug-resistant non-small cell lung cancer to gefitinib by suppression of PI3K/Akt signaling pathway and inhibites cell migration via targeting ZEB1

作者：Guohua Zhou, Zhang Fangli, Guo Yu, Jianfei Huang, Yaqiong Xie, Shuanglei Yue, Ming‐Hui Chen, Hao Jiang, Mengjie Li · 发表于：Biomedicine & Pharmacotherapy · 年份：2016 · DOI：10.1016/j.biopha.2016.11.100 · 被引用次数：120 · 研究领域：MicroRNA in disease regulation、Lung Cancer Treatments and Mutations、Cholangiocarcinoma and Gallbladder Cancer Studies